|
Market Closed -
Euronext Paris
16:55:00 20/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.446 EUR | +7.66% |
|
+17.15% | -63.49% |
| 09-25 | Adocia plunges, cash position raises concerns |  |
| 09-17 | Adocia Presents Data On AdoShell Platform Scalability And BioChaperone Lispro Phase 3 Results | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 50.99M | - | ||||
| 65.83B | |||||
| 51.87B | |||||
| 51.2B | |||||
| 43.76B | |||||
| 42.09B |
- Stock Market
- Stocks
- ADOC Stock
- Charts Adocia
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
